SkinVision
AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.
Last updated: June 5, 2026
Back to directoryHealthcare AI agent platform for automating routine patient access conversations across phone, SMS, web, and mobile channels.
Patient access teams that need to deflect routine calls while keeping escalation and operational visibility.
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Hyro as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat Hyro as patient-access infrastructure unless the configured agent starts handling symptoms, medication questions, or clinical guidance that could change the regulatory and clinical accountability profile. |
|---|---|
| Privacy | Verify the actual healthcare deployment terms for PHI, patient record access, recordings, SMS or chat retention, Epic or CRM integrations, and any BAA or customer-specific privacy obligations. |
| Evidence | Vendor accuracy and ROI claims should be treated as case-study signals only; measure automation, abandonment, handoff quality, incorrect routing, and unsafe-answer rates on your own intents before scaling. |
| Workflow | Define exactly which requests are auto-resolved, which are routed, and which require staff takeover so the agent stays within approved access and support boundaries. |
Hyro describes responsible AI agents for patient support, call center automation, scheduling, and smart routing across phone, web, SMS, and mobile channels, with explainability, control, and compliance positioned as deployment pillars.
Not for: Unbounded clinical advice, emergency triage, medication decisions, or symptom reassurance without escalation scripts.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.